Form D · Biotechnology
Boston Translational LLC
Allston, MA · CIK 0001717227
Offering snapshot reported Apr 16, 2018 · SEC filing
- Reported sold
- $1.83M Offering amount: $4M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Sep 7, 2017 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,575,000 → $1,825,000
- Reported investors2 → 4
- Minimum accepted$75,000 → $25,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 16, 2018 | Amendment | $1,825,000 | $250,000vs Sep 18, 2017 | 4 | SEC filing |
| Sep 18, 2017 | Initial | $1,575,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-294903
Per the operating agreement, investors receive return of their invested capital plus a preferred return percentage (before distributions are made according to % ownership) in addition to an equity state in the LLC.
Source: Form D, filed Apr 16, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Holzer | Director, Executive, Promoter |
| Krysta Moulton | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
41 Haskell St Unit 2
Allston, MA, 02134
Allston, MA, 02134